Accuro Epidural Guidance Device Demonstrated Superior for Spinal Anesthesia Administration Compared to Palpation & Conventional Ultrasound in a Parturient With Extreme Obesity CHARLOTTESVILLE, Va., Aug. 16, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, announced the results of a clinical case study demonstrating that Accuro...

RIVANNA® Names Mikel Lewis Director of Manufacturing Operations CHARLOTTESVILLE, Va., July 13, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, has appointed Mikel Lewis, an experienced life science and medical...

RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial...

RIVANNA's Accuro Automatically Identifies and Measures Epidural Space Depth With Accuracy Equivalent to Standard Ultrasound in Obese Pregnant Women CHARLOTTESVILLE, Va., Sept. 13, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a prospective, double-blind study...